✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Madrigal Pharmaceuticals Inc

Common Name
Madrigal Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
915
Ticker
MDGL
Exchange
NASDAQ/NGS
Description
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), also known ...

Disclosures of Madrigal Pharmaceuticals

Explore Madrigal Pharmaceuticals's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Madrigal Pharmaceuticals's official channels and fully traceable to its official company sources.

The table below lists all of Madrigal Pharmaceuticals's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

Fiscal Year / TypeLanguages
20241 disclosure
10-K
en
20231 disclosure
10-K
en
20222 disclosures
10-K
en
10-K
en
20211 disclosure
10-K
en
20201 disclosure
10-K
en
20191 disclosure
10-K
en
20182 disclosures
10-K
en
10-K
en
20171 disclosure
10-K
en
20161 disclosure
10-K
en
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?